AR109262A1 - ANTIBODIES AGAINST TIM3 AND ITS USES - Google Patents
ANTIBODIES AGAINST TIM3 AND ITS USESInfo
- Publication number
- AR109262A1 AR109262A1 ARP170101959A ARP170101959A AR109262A1 AR 109262 A1 AR109262 A1 AR 109262A1 AR P170101959 A ARP170101959 A AR P170101959A AR P170101959 A ARP170101959 A AR P170101959A AR 109262 A1 AR109262 A1 AR 109262A1
- Authority
- AR
- Argentina
- Prior art keywords
- seq
- cdr3
- antigen binding
- antibodies against
- cdr2
- Prior art date
Links
- 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 title 1
- 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Anticuerpos, o porciones de fijación al antígeno de estos, que se fijan a la proteína 3 que contiene el dominio de mucina e inmunoglobulina de linfocitos T (TIM3). Reivindicación 13: El anticuerpo, o la porción de fijación al antígeno de este, de acuerdo con cualquiera de las reivindicaciones anteriores, caracterizado porque el anticuerpo, o la porción de fijación al antígeno de este, comprende CDR1, CDR2 y CDR3 de la cadena pesada y CDR1, CDR2 y CDR3 de la cadena liviana, en donde CDR3 de la cadena pesada comprende una secuencia de aminoácidos seleccionada del grupo que consiste en: SEQ ID Nº 53, SEQ ID Nº 54, SEQ ID Nº 55, SEQ ID Nº 56, SEQ ID Nº 57, SEQ ID Nº 58, SEQ ID Nº 59, SEQ ID Nº 126, SEQ ID Nº 127, SEQ ID Nº 128 o SEQ ID Nº 129.Antibodies, or antigen binding portions thereof, that bind to protein 3 that contains the mucin and immunoglobulin domain of T lymphocytes (TIM3). Claim 13: The antibody, or the antigen binding portion thereof, according to any of the preceding claims, characterized in that the antibody, or the antigen binding portion thereof, comprises CDR1, CDR2 and CDR3 of the heavy chain and CDR1, CDR2 and CDR3 of the light chain, wherein CDR3 of the heavy chain comprises an amino acid sequence selected from the group consisting of: SEQ ID No. 53, SEQ ID No. 54, SEQ ID No. 55, SEQ ID No. 56, SEQ ID No. 57, SEQ ID No. 58, SEQ ID No. 59, SEQ ID No. 126, SEQ ID No. 127, SEQ ID No. 128 or SEQ ID No. 129.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662362541P | 2016-07-14 | 2016-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR109262A1 true AR109262A1 (en) | 2018-11-14 |
Family
ID=64498539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170101959A AR109262A1 (en) | 2016-07-14 | 2017-07-13 | ANTIBODIES AGAINST TIM3 AND ITS USES |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR109262A1 (en) |
| MA (1) | MA45661A (en) |
-
2017
- 2017-07-13 AR ARP170101959A patent/AR109262A1/en not_active Application Discontinuation
- 2017-07-13 MA MA045661A patent/MA45661A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA45661A (en) | 2019-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124771T1 (en) | ANTI-SORTILINE ANTIBODIES AND METHODS OF USING THEM | |
| PE20181805A1 (en) | COMPOSITIONS AND ANTI-TIM-3 ANTIBODIES | |
| MX2019005116A (en) | Antibodies directed against t cell immunoglobulin and mucin protein 3 (tim-3). | |
| ES2687282T3 (en) | ANTI-CD134 (OX40) humanized antibodies and their uses | |
| MX366359B (en) | Humanized antibodies against ceacam1. | |
| UY36536A (en) | ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BIESPECIFIC ANTIBODIES THAT SPECIFICALLY JOIN CD3 AND / OR CD123 | |
| PE20190737A1 (en) | ANTI-CD27 ANTIBODIES | |
| AR096617A1 (en) | ANTI-TWEAKR ANTIBODIES AND THEIR USES | |
| PE20170665A1 (en) | HUMANIZED ANTI-TAU ANTIBODIES | |
| AR108066A1 (en) | CHEMICAL RECEIVERS FOR CLL-1 AND METHODS OF USE OF THE SAME | |
| NZ743713A (en) | Human immunodeficiency virus neutralizing antibodies | |
| EA201591153A1 (en) | ANTIBODIES CONNECTING TL1A AND THEIR APPLICATION | |
| CO6231038A2 (en) | UNION PROTEINS, INCLUDING ANTIBODIES DERIVED FROM ANTIBODY AND ANTIBODY FRAGMENTS THAT SPECIFICALLY JOIN CD154 AND ITS USES | |
| WO2014144542A3 (en) | Methods of generating bioactive peptide-bearing antibodies and compositions comprising the same | |
| CL2018003072A1 (en) | Humanized anti-basigin antibodies and their use. | |
| CL2017000756A1 (en) | Binding molecules, especially antibodies, that bind to l1cam (cd171) | |
| AR109683A1 (en) | ANTIBODIES AGAINST FACTOR XI AND ITS USES | |
| EA201790816A1 (en) | ANTIBODIES THAT ARE ASSOCIATED WITH CCR6 AND APPLICATION OPTIONS FOR THE INDICATED ANTIBODIES | |
| EP4356972A3 (en) | Anti-annexin a2 monoclonal antibodies | |
| AR100427A1 (en) | PROTEINS OF UNION TO ANTIGEN OF HER1 THAT JOIN THE FORK b OF HER1 | |
| AR109262A1 (en) | ANTIBODIES AGAINST TIM3 AND ITS USES | |
| AR099604A1 (en) | METALOPROTEINASE MATRIX 9 ANTIBODIES AND THEIR METHODS OF USE | |
| EP4115904A3 (en) | Anti-rspo3 antibodies | |
| AR107083A1 (en) | ANTIBODIES DIRECTED TO CD32B AND METHODS OF USE OF THE SAME | |
| EA201990743A1 (en) | ANTIBODIES AIMED AGAINST PROTEIN-3 CONTAINING T-CELL IMMUNOGLOBULIN AND MUCIN (TIM-3) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure | ||
| FA | Abandonment or withdrawal |